TSMHT
CERE

Thurston Springer Miller Herd & Titak’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,107
Closed -$127K – 1582
2024
Q2 		$127K Buy
+3,107
New +$127K 0.04% 371